Ezallor Sprinkle is owned by Sun Pharm.
Ezallor Sprinkle contains Rosuvastatin Calcium.
Ezallor Sprinkle has a total of 1 drug patent out of which 0 drug patents have expired.
Ezallor Sprinkle was authorised for market use on 18 December, 2018.
Ezallor Sprinkle is available in capsule;oral dosage forms.
The generics of Ezallor Sprinkle are possible to be released after 12 February, 2036.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US10413543||SUN PHARM||Stable multiparticulate pharmaceutical composition of rosuvastatin|| |
(13 years from now)
Market Authorisation Date: 18 December, 2018
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic